姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Que,Yuan-Long | Chairman | 100.00% | Yulon Finance Corporation |
Huang,De-Chao | Director | 100.00% | Yulon Finance Corporation |
Chen,Fa-Ke | Director | 100.00% | Yulon Finance Corporation |
Lai,Bai-An | Director | 100.00% | Yulon Finance Corporation |
Liu,Mei-Qin | Director | 100.00% | Yulon Finance Corporation |
Liao,Shu-Hua | Supervisor | 100.00% | Yulon Finance Corporation |
Chen,Yuan-Long | Supervisor | 100.00% | Yulon Finance Corporation |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 6,903,519 | 5,864,725 | 4,291,303 |
Operating cost | 1,548,117 | 1,248,514 | 700,021 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 5,355,402 | 4,616,211 | 3,591,282 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 5,355,402 | 4,616,211 | 3,591,282 |
Operating expenses | 2,794,069 | 2,284,526 | 1,739,201 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 2,561,333 | 2,331,685 | 1,852,081 |
Non-operating income and expenses | -34,105 | 2,044 | 87,921 |
Net profit (loss) before tax | 2,527,228 | 2,333,729 | 1,940,002 |
Income tax expense (benefits) | 501,627 | 529,618 | 402,770 |
Net profit (loss) of ongoing business for the current period | 2,025,601 | 1,804,111 | 1,537,232 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 2,025,601 | 1,804,111 | 1,537,232 |
Other comprehensive profit (loss), net | 50,538 | -18,870 | 1,700 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 2,076,139 | 1,785,241 | 1,538,932 |
Net profit (loss) attributable to owners of parent company | 2,028,971 | 1,804,467 | 1,537,232 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | -3,370 | -356 | - |
Comprehensive profit (loss) attributable to owners of parent company | 2,084,157 | 1,785,597 | 1,538,932 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | -8,018 | -356 | - |
Basic earnings per share (yuan) | 3 | 3 | 3 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | -7,460,383 | -8,833,013 | -14,988,712 |
Net cash inflows (outflows) from investing activities | -5,245,910 | -2,274,258 | -1,577,580 |
Net cash inflow (outflow) from financing activities | 12,903,905 | 11,450,032 | 16,912,996 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 22,710 | -9,556 | -5 |
Increase (decrease) in cash and cash equivalents in the current period | 220,322 | 333,205 | 346,699 |
Beginning balance of cash and cash equivalents | 1,323,548 | 990,343 | 643,644 |
Ending balance of cash and cash equivalents | 1,543,870 | 1,323,548 | 990,343 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 91,603,533 | 80,323,109 | 68,401,672 |
Non-current asset | 10,140,733 | 5,262,972 | 2,484,078 |
Total asset | 101,744,266 | 85,586,081 | 70,885,750 |
Current liability | 81,039,047 | 67,768,928 | 60,717,618 |
Non-current liability | 3,295,532 | 1,088,307 | 773,936 |
Total liability | 84,334,579 | 68,857,235 | 61,491,554 |
share capital | 5,578,000 | 5,578,000 | 4,303,000 |
Equity - secruity token | - | - | - |
capital reserve | 6,657,071 | 6,642,796 | 2,417,228 |
retained earning | 4,900,089 | 4,526,854 | 2,721,961 |
Other equity | -12,905 | -67,289 | -47,993 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 17,122,255 | 16,680,361 | 9,394,196 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | 287,432 | 48,485 | - |
Total Equity | 17,409,687 | 16,728,846 | 9,394,196 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 30 | 29 | 21 |
標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
---|---|---|---|---|
屏東榮民總醫院112年資本門設備乙案(彩色光譜電腦斷層 +高壓注射器+病患生理監視器) | 屏東榮民總醫院 | 112/07/18 | 66800000.0 | 是 |
高雄市立高雄高級工業職業學校112年度公有房舍設置太陽光電發電系統租賃案(屋頂型) | 高雄市立高雄高級工業職業學校 | 112/05/11 | 383154.0 | 是 |
濁幹線(三合里區段)太陽光電發電系統計畫案 | 行政院農業委員會農田水利署 | 112/03/29 | 否 | |
屏東榮民總醫院111年醫療設備等13案 | 高雄榮民總醫院 | 111/12/22 | 8130000.0 | 是 |
屏東(大武)分院111年醫療設備乙項(高階彩色心臟超音波掃描儀(含探頭) | 高雄榮民總醫院 | 111/06/16 | 10168888.0 | 是 |
屏東(大武)分院111年醫療設備等8案 | 高雄榮民總醫院 | 111/06/08 | 1960000.0 | 是 |
第二心導管室建置案-雙向心導管X光機及周邊設備(含房間工程) | 高雄市立聯合醫院 | 110/10/26 | 79680000.0 | 是 |
屏東(大武)分院111年醫療設備等4項 | 高雄榮民總醫院 | 110/09/17 | 82200000.0 | 是 |
屏東(大武)分院111年醫療設備等34項 | 高雄榮民總醫院 | 110/09/14 | 23600000.0 | 是 |
高階彩色心臟定量超音波掃描儀1台 | 高雄榮民總醫院 | 108/02/26 | 7900000.0 | 是 |
複合手術室 | 高雄榮民總醫院 | 108/01/30 | 88768888.0 | 是 |